Evidence map›Paper›PMID 35265083›Full record

ArticleFrontiers in immunology2022

Baicalein-A Potent Pro-Homeostatic Regulator of Microglia in Retinal Ischemic Injury.

Li Pan, Ying Hon Sze, Menglu Yang, Jing Tang, Siming Zhao, Irvin Yi, Chi-Ho To, Chuen Lam, Dong Feng Chen, Kin-Sang Cho and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Retinal ischemia-reperfusion injury and pretreatment withInternational journal of ophthalmology · 2024
    Article
  7. Microglia at the blood brain barrier in health and disease.Frontiers in cellular neuroscience · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Li PanSchool of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Ying Hon SzeSchool of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Menglu YangSchepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States.
Jing TangSchepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States.
Siming ZhaoSchepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States.
Irvin YiSchepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States.
Chi-Ho ToSchool of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Chuen LamSchool of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Dong Feng ChenSchepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States.
Kin-Sang ChoSchepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States.
Chi-Wai DoSchool of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Hong Kong Polytechnic University · HKMassachusetts Eye and Ear Infirmary · USSmith-Kettlewell Eye Research Institute · USSichuan University · CN

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
Innate and Adaptive Immunity in the Pathogenesis of GlaucomaR01EY031696 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Dong Feng Chen, Jianzhu Chen · 2021 to 2026
$5.2M
The Molecular Basis Underlying Optic Nerve Growth in Development and RegenerationR01EY025259 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI CHEN, DONG FENG · 2016 to 2020
$3.2M
Development of a Next Generation Visual Performance Assessment System for RodentsR44EY025913 · NEI · AFASCI, INC. · PI CHEN, DONG FENG, LUO, GANG · 2019 to 2020
$1.5M
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolaseR43DA059524 · NIDA · AFASCI, INC. · PI XIE, XINMIN SIMON · 2023 to 2023
$320k
NEI NIH HHS P30 EY003790NEI NIH HHS R01 EY025259NEI NIH HHS R01 EY031696NEI NIH HHS R44 EY025913NIDA NIH HHS R43 DA059524
6 · The paper itself

Abstract

Retinal ischemia is a common cause of many retinal diseases, leading to irreversible vision impairment and blindness. Excessive neuroinflammation, including microglial activation and T-cell responses, has been identified as a critical factor associated with neurodegeneration in retinal ischemia. Baicalein is a natural flavonoid reported to have broad anti-inflammatory and neuroprotective bioactivities. Herein, the effects of baicalein on microglia activation

Indexed as

Reperfusion InjuryRetinal DiseasesAnimalsAnti-Inflammatory AgentsFlavanonesFlavonoidsIschemiaMiceMicrogliaPhosphatidylinositol 3-KinasesProteomicsAnti-Inflammatory AgentsbaicaleinFlavanonesFlavonoidsPhosphatidylinositol 3-KinasesbaicaleinIL-1βmicroglianeuroinflammationproteomicsretinal ischemiaTh17 cell

Identifiers

PMID35265083
PMCPMC8899187
OpenAlexW4212850391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.